Cite
Ziauddeen H, Nestor LJ, Subramaniam N, et al. Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype. Neuropsychopharmacology. 2018;43(4):927doi: 10.1038/npp.2017.287.
Ziauddeen, H., Nestor, L. J., Subramaniam, N., Dodds, C., Nathan, P. J., Miller, S. R., Sarai, B. K., Maltby, K., Fernando, D., Warren, L., Hosking, L. K., Waterworth, D., Korzeniowska, A., Win, B., Richards, D. B., Johnson, L. V., Fletcher, P. C., & Bullmore, E. T. (2018). Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 43(4), 927. https://doi.org/10.1038/npp.2017.287
Ziauddeen, Hisham, et al. "Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology vol. 43,4 (2018): 927. doi: https://doi.org/10.1038/npp.2017.287
Ziauddeen H, Nestor LJ, Subramaniam N, Dodds C, Nathan PJ, Miller SR, Sarai BK, Maltby K, Fernando D, Warren L, Hosking LK, Waterworth D, Korzeniowska A, Win B, Richards DB, Johnson LV, Fletcher PC, Bullmore ET. Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype. Neuropsychopharmacology. 2018 Mar;43(4):927. doi: 10.1038/npp.2017.287. PMID: 29422496; PMCID: PMC5809804.
Copy
Download .nbib